Viewing Study NCT01722305


Ignite Creation Date: 2025-12-25 @ 3:15 AM
Ignite Modification Date: 2026-02-28 @ 6:05 PM
Study NCT ID: NCT01722305
Status: COMPLETED
Last Update Posted: 2019-07-22
First Post: 2012-11-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma or Newly Diagnosed or Relapsed or Refractory Intraocular Lymphoma
Sponsor: Mayo Clinic
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module